Top news
NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19
Fauci says leak concerns fueled his White House revelation of Gilead drug results
By Julie Steenhuysen
Gilead’s remdesivir shows some benefit in early results as coronavirus treatment
By Laurie McGinley & Christopher Rowland
All coverage
Trump wants FDA to move 'as quickly as they can' on remdesivir coronavirus approval
By Berkeley Lovelace & Berkeley Lovelace Jr.
FDA issues emergency-use authorization for remdesivir to treat hospitalized patients with severe Covid-19
By Arman Azad & Nicole Chavez
Remdesivir-Maker Gilead's Lobbying Hit New High In 1st Quarter : Shots - Health News
By Sydney Lupkin
Critical study of Gilead's Covid-19 drug shows patients are responding to treatment, NIH says
By Matthew Herper & Adam Feuerstein
FDA OKs Gilead Coronavirus Drug Remdesivir Emergency Use: Trump
By Anna Edney, Michelle Cortez & Justin Sink
Remdesivir Shows Modest Benefits in Coronavirus Trial
By Gina Kolata, Peter Baker & Noah Mercer Weiland
Researchers changed criteria for assessing Gilead’s drug remdesivir in coronavirus treatment trials
By Christopher Rowland
Dr. Anthony Fauci says Gilead's remdesivir will set a new 'standard of care' for coronavirus treatment
By Berkeley Lovelace & Berkeley Lovelace Jr.